Product Name

  • Name

    5-Chlorouracil

  • EINECS 217-339-7
  • CAS No. 1820-81-1
  • Article Data26
  • CAS DataBase
  • Density 1.61 g/cm3
  • Solubility slightly soluble in water
  • Melting Point >300 °C(lit.)
  • Formula C4H3ClN2O2
  • Boiling Point 413.6 °C at 760 mmHg
  • Molecular Weight 146.533
  • Flash Point 203.9 °C
  • Transport Information
  • Appearance white to light beige crystalline powder
  • Safety 22-24/25-36-26
  • Risk Codes 36/37/38
  • Molecular Structure Molecular Structure of 1820-81-1 (5-Chlorouracil)
  • Hazard Symbols IrritantXi
  • Synonyms 2,4 (1H,3H)-Pyrimidinedione, 5-chloro-;2,4(1H,3H)-Pyrimidinedione, 5-chloro-;Uracil, 5-chloro- (VAN) (8CI);Uracil, 5-chloro-;5-Chloro-2,4-pyrimidinedione;5-Chlorouracil,5-Chloro-2,4-dihydroxypyrimidine;
  • PSA 65.72000
  • LogP -0.28340

Synthetic route

uracil
66-22-8

uracil

5-chlorouracil
1820-81-1

5-chlorouracil

Conditions
ConditionsYield
With 1,2-Dichloro-3-iodobenzene In water; acetic acid at 80℃; for 0.25h;92%
With hydrogenchloride; ammonium cerium(IV) nitrate In methanol at 70℃; for 5.5h;82%
With sodium hydrogencarbonate; lithium chloride In acetonitrile Ambient temperature; electrolysis (Pt electrodes, SCE reference, LiClO4 as supporting electrolyte);77%
With potassium phosphate; potassium chloride; dihydrogen peroxide; chloroperoxidase pH 3;7%
5-chloro-2,4-dimethoxypyrimidine
123551-49-5

5-chloro-2,4-dimethoxypyrimidine

5-chlorouracil
1820-81-1

5-chlorouracil

Conditions
ConditionsYield
With hydrogenchloride69%
5-methoxycarbonyluracil

5-methoxycarbonyluracil

5-chlorouracil
1820-81-1

5-chlorouracil

Conditions
ConditionsYield
With hydrogenchloride; chlorine In water for 16h; Heating;63%
uracil
66-22-8

uracil

A

5-chlorouracil
1820-81-1

5-chlorouracil

B

5,5-dichloro-6-hydroxy-5,6-dihydrouracil
2072-83-5

5,5-dichloro-6-hydroxy-5,6-dihydrouracil

Conditions
ConditionsYield
With sodium persulfate; water; sodium chloride In acetic acid at 100 - 105℃;A 20%
B 53%
With sodium persulfate; water; sodium chloride In acetic acid at 100 - 105℃;A 20%
B 53%
5-chloro-6-hydroxy-5-methoxycarbonyl-5,6-dihydrouracil
65906-87-8

5-chloro-6-hydroxy-5-methoxycarbonyl-5,6-dihydrouracil

5-chlorouracil
1820-81-1

5-chlorouracil

Conditions
ConditionsYield
With hydrogenchloride In water for 15h; Heating;27%
In hydrogenchloride
N-chloro-succinimide
128-09-6

N-chloro-succinimide

acetic anhydride
108-24-7

acetic anhydride

acetic acid
64-19-7

acetic acid

uracil
66-22-8

uracil

5-chlorouracil
1820-81-1

5-chlorouracil

N-chloro-succinimide
128-09-6

N-chloro-succinimide

uracil
66-22-8

uracil

5-chlorouracil
1820-81-1

5-chlorouracil

2-ethylmercapto-5-chloro-3H-pyrimidin-4-one
106146-79-6

2-ethylmercapto-5-chloro-3H-pyrimidin-4-one

5-chlorouracil
1820-81-1

5-chlorouracil

Conditions
ConditionsYield
With hydrogenchloride
1-α-D-arabinopyranosyl-5-chloro-1H-pyrimidine-2,4-dione

1-α-D-arabinopyranosyl-5-chloro-1H-pyrimidine-2,4-dione

5-chlorouracil
1820-81-1

5-chlorouracil

Conditions
ConditionsYield
With hydrogenchloride
1-acetyl-1H-pyrimidine-2,4-dione
40338-28-1

1-acetyl-1H-pyrimidine-2,4-dione

5-chlorouracil
1820-81-1

5-chlorouracil

Conditions
ConditionsYield
Yield given. Multistep reaction;
5-Chloro-6-hydroxyamino-dihydro-pyrimidine-2,4-dione

5-Chloro-6-hydroxyamino-dihydro-pyrimidine-2,4-dione

5-chlorouracil
1820-81-1

5-chlorouracil

Conditions
ConditionsYield
With hydroxylamine at 25℃; Equilibrium constant; var. pH;
(+-)-5,5-dichloro-6-methoxy-dihydro-pyrimidine-2,4-dione

(+-)-5,5-dichloro-6-methoxy-dihydro-pyrimidine-2,4-dione

5-chlorouracil
1820-81-1

5-chlorouracil

Conditions
ConditionsYield
With hydrogenchloride; tin
5.5-dichloro-4-oxy-dihydrouracil

5.5-dichloro-4-oxy-dihydrouracil

5-chlorouracil
1820-81-1

5-chlorouracil

Conditions
ConditionsYield
With hydrogenchloride; tin
uracil
66-22-8

uracil

A

5-chlorouracil
1820-81-1

5-chlorouracil

B

5.5-dichloro-4-oxy-dihydrouracil

5.5-dichloro-4-oxy-dihydrouracil

Conditions
ConditionsYield
With chlorine
5-chloro-2'-deoxyuridine
50-90-8

5-chloro-2'-deoxyuridine

5-chlorouracil
1820-81-1

5-chlorouracil

Conditions
ConditionsYield
With phosphate buffer; thymidine phosphorylase from Escherichia coli at 37℃; pH=7; Enzyme kinetics; Further Variations:; concentration of reagent;
methyl 2,4-dioxo-1,2,3,4-tetrahydropyrimidine-5-carboxylate
42821-92-1

methyl 2,4-dioxo-1,2,3,4-tetrahydropyrimidine-5-carboxylate

5-chlorouracil
1820-81-1

5-chlorouracil

Conditions
ConditionsYield
With hydrogenchloride In water
5-chlorouracil
1820-81-1

5-chlorouracil

C4H4ClN2O2
65094-55-5

C4H4ClN2O2

Conditions
ConditionsYield
With H2SO4 glasses Product distribution; Irradiation;100%
chloro-trimethyl-silane
75-77-4

chloro-trimethyl-silane

5-chlorouracil
1820-81-1

5-chlorouracil

5-chloro-2,4-bis-O-trimethylsilyluracil
58990-53-7

5-chloro-2,4-bis-O-trimethylsilyluracil

Conditions
ConditionsYield
With 1,1,1,3,3,3-hexamethyl-disilazane Ambient temperature;99%
5-chlorouracil
1820-81-1

5-chlorouracil

sodium thiophenolate
930-69-8

sodium thiophenolate

5-(phenylsulfanyl)-2,4(1H,3H)-pyrimidinedione
1137-90-2

5-(phenylsulfanyl)-2,4(1H,3H)-pyrimidinedione

Conditions
ConditionsYield
In N,N,N,N,N,N-hexamethylphosphoric triamide at 150℃; for 0.0833333h; microwave irradiation;97%
5-chlorouracil
1820-81-1

5-chlorouracil

ethyl acrylate
140-88-5

ethyl acrylate

3-(5-chloro-2,4-dioxo-3,4-dihydro-2H-pyrimidin-1-yl)propionic acid ethyl ester
1370413-72-1

3-(5-chloro-2,4-dioxo-3,4-dihydro-2H-pyrimidin-1-yl)propionic acid ethyl ester

Conditions
ConditionsYield
With triethylamine In N,N-dimethyl-formamide at 60℃; Aza-Micheal reaction;96%
5-chlorouracil
1820-81-1

5-chlorouracil

2,4,5-trichloropyrimidine
5750-76-5

2,4,5-trichloropyrimidine

Conditions
ConditionsYield
With phosphorus pentachloride; trichlorophosphate Neat (no solvent); Heating / reflux;95%
With phosgene; Triphenylphosphine oxide In nitrobenzene at -5 - 125℃; for 0.833333h; Inert atmosphere;93%
With N,N-diethylaniline; trichlorophosphate at 110℃; for 24h;81%
5-chlorouracil
1820-81-1

5-chlorouracil

1,1,1,3,3,3-hexamethyl-disilazane
999-97-3

1,1,1,3,3,3-hexamethyl-disilazane

5-chloro-2,4-bis-O-trimethylsilyluracil
58990-53-7

5-chloro-2,4-bis-O-trimethylsilyluracil

Conditions
ConditionsYield
With ammonium sulfate for 5h; Heating;95%
With chloro-trimethyl-silane Heating;
With ammonium sulfate for 3h; Heating;
5-chlorouracil
1820-81-1

5-chlorouracil

acrylic acid methyl ester
292638-85-8

acrylic acid methyl ester

3-(5-chloro-2,4-dioxo-3,4-dihydro-2H-pyrimidin-1-yl)propionic acid methyl ester
1256346-76-5

3-(5-chloro-2,4-dioxo-3,4-dihydro-2H-pyrimidin-1-yl)propionic acid methyl ester

Conditions
ConditionsYield
With triethylamine In N,N-dimethyl-formamide at 60℃; for 4h; Michael Addition;95%
With triethylamine In N,N-dimethyl-formamide at 20℃; Michael-type addition; regioselective reaction;88%
5-chlorouracil
1820-81-1

5-chlorouracil

acrylic acid n-butyl ester
141-32-2

acrylic acid n-butyl ester

3-(5-chloro-2,4-dioxo-3,4-dihydro-2H-pyrimidin-1-yl)propionic acid butyl ester
1370413-75-4

3-(5-chloro-2,4-dioxo-3,4-dihydro-2H-pyrimidin-1-yl)propionic acid butyl ester

Conditions
ConditionsYield
With triethylamine In N,N-dimethyl-formamide at 60℃; Aza-Micheal reaction;95%
5-chlorouracil
1820-81-1

5-chlorouracil

1-chloro-2,4-dinitro-benzene
97-00-7

1-chloro-2,4-dinitro-benzene

1-(2,4-dinitro-phenyl)-5-chloro-1H-pyrimidine-2,4-dione

1-(2,4-dinitro-phenyl)-5-chloro-1H-pyrimidine-2,4-dione

Conditions
ConditionsYield
With zinc(II) oxide at 130℃; for 0.1h; Ionic liquid; Microwave irradiation;92%
5-chlorouracil
1820-81-1

5-chlorouracil

5-Chloro-4-thiouracil
63331-62-4

5-Chloro-4-thiouracil

Conditions
ConditionsYield
With diphosphorus pentasulfide; sodium hydrogencarbonate In diethylene glycol dimethyl ether at 110℃; for 3h;90%
5-chlorouracil
1820-81-1

5-chlorouracil

α-D-glucopyranose peracetylate
604-68-2

α-D-glucopyranose peracetylate

5-chloro-1-(2,3,4,6-tetra-O-acetyl-β-D-gluco-hexopyranosyl)uracil
379218-39-0

5-chloro-1-(2,3,4,6-tetra-O-acetyl-β-D-gluco-hexopyranosyl)uracil

Conditions
ConditionsYield
Stage #1: 5-chlorouracil With 1,1,1,3,3,3-hexamethyl-disilazane; saccharin In acetonitrile for 3h; Heating;
Stage #2: α-D-glucopyranose peracetylate With trimethylsilyl trifluoromethanesulfonate In acetonitrile at 20 - 85℃;
90%
5-chlorouracil
1820-81-1

5-chlorouracil

benzylamine
100-46-9

benzylamine

5-(benzylamino)dihydropyrimidine-2,4(1H,3H)-dione
28485-19-0

5-(benzylamino)dihydropyrimidine-2,4(1H,3H)-dione

Conditions
ConditionsYield
at 150℃; for 0.333333h; microwave irradiation;88%
5-chlorouracil
1820-81-1

5-chlorouracil

1,8-diazabicyclo[5.4.0]undec-7-ene
6674-22-2

1,8-diazabicyclo[5.4.0]undec-7-ene

2,3,4,6,7,8,9,10-octahydro-pyrimido[1,2-a]azepine; compound with 5-chloro-1H-pyrimidine-2,4-dione

2,3,4,6,7,8,9,10-octahydro-pyrimido[1,2-a]azepine; compound with 5-chloro-1H-pyrimidine-2,4-dione

Conditions
ConditionsYield
In acetonitrile at 20℃;87%
5-chlorouracil
1820-81-1

5-chlorouracil

adenosine
58-61-7

adenosine

C4H3ClN2O2*C10H13N5O4
1369492-08-9

C4H3ClN2O2*C10H13N5O4

Conditions
ConditionsYield
In ethanol; chloroform; water for 8h; Reflux;84%
5-chlorouracil
1820-81-1

5-chlorouracil

[Zn(OH)(hydrotris(3-tert-butyl-5-isopropyl-1-pyrazolyl)borate)]

[Zn(OH)(hydrotris(3-tert-butyl-5-isopropyl-1-pyrazolyl)borate)]

[Zn(hydrotris(3-tert-butyl-5-isopropyl-1-pyrazolyl)borate)(5-chlorouracilate)]

[Zn(hydrotris(3-tert-butyl-5-isopropyl-1-pyrazolyl)borate)(5-chlorouracilate)]

Conditions
ConditionsYield
In methanol; dichloromethane (N2); using Schlenk techniques; addn. of suspn. of 5-chlorouracil in methanol to soln. of Zn(HB(Me3CC3HN2CHMe2)3)(OH) in CH2Cl2; stirring overnight; filtration, evapn. of solvent, drying under vac., elem. anal.;81%
5-chlorouracil
1820-81-1

5-chlorouracil

N-hydroxy-4-methylbenzenecarboximidoyl chloride
36288-37-6

N-hydroxy-4-methylbenzenecarboximidoyl chloride

6-chloro-3-(p-tolyl)-5H-[1,2,4]oxadiazolo[4,5-a]pyrimidin-5-one

6-chloro-3-(p-tolyl)-5H-[1,2,4]oxadiazolo[4,5-a]pyrimidin-5-one

Conditions
ConditionsYield
With dmap In 1,4-dioxane for 5h; Reflux;80%
5-chlorouracil
1820-81-1

5-chlorouracil

trimethylsilyl trifluoromethanesulfonate
27607-77-8

trimethylsilyl trifluoromethanesulfonate

3,4,6-tris-O-tert-butyldimethylsilyl-1,2-anhydro-α-D-glucopyranose
121654-00-0

3,4,6-tris-O-tert-butyldimethylsilyl-1,2-anhydro-α-D-glucopyranose

1-[3′,4′,6′-tri-O-(tert-butyldimethylsilyl)-2-O-trimethylsilyl-β-D-glucopyranosyl]-5-chloro-2,4(1H,3H)-pyrimidinedione

1-[3′,4′,6′-tri-O-(tert-butyldimethylsilyl)-2-O-trimethylsilyl-β-D-glucopyranosyl]-5-chloro-2,4(1H,3H)-pyrimidinedione

Conditions
ConditionsYield
Stage #1: 5-chlorouracil With 1,1,1,3,3,3-hexamethyl-disilazane at 120℃; for 1.5h; Inert atmosphere;
Stage #2: trimethylsilyl trifluoromethanesulfonate; 3,4,6-tris-O-tert-butyldimethylsilyl-1,2-anhydro-α-D-glucopyranose at 60℃; for 3h; Inert atmosphere;
80%
5-chlorouracil
1820-81-1

5-chlorouracil

4-ethyl-N-hydroxybenzene-1-carboximidoyl chloride
61946-91-6

4-ethyl-N-hydroxybenzene-1-carboximidoyl chloride

6-chloro-3-(4-ethylphenyl)-5H-[1,2,4]oxadiazolo[4,5-a]pyrimidin-5-one

6-chloro-3-(4-ethylphenyl)-5H-[1,2,4]oxadiazolo[4,5-a]pyrimidin-5-one

Conditions
ConditionsYield
With dmap In 1,4-dioxane for 5h; Reflux;79%
5-chlorouracil
1820-81-1

5-chlorouracil

trimethylsilyl trifluoromethanesulfonate
27607-77-8

trimethylsilyl trifluoromethanesulfonate

1,2-anhydro-3,4,6-tri-O-benzyl-β-D-mannopyranose
74372-90-0, 112289-38-0, 135202-48-1, 148888-66-8, 71696-32-7

1,2-anhydro-3,4,6-tri-O-benzyl-β-D-mannopyranose

1-[3′,4′,6′-tri-O-(benzyl)-2-O-trimethylsilyl-glucopyranosyl]-5-chloro-2,4(1H,3H)-pyrimidinedione

1-[3′,4′,6′-tri-O-(benzyl)-2-O-trimethylsilyl-glucopyranosyl]-5-chloro-2,4(1H,3H)-pyrimidinedione

Conditions
ConditionsYield
Stage #1: 5-chlorouracil With 1,1,1,3,3,3-hexamethyl-disilazane at 120℃; for 1.5h; Inert atmosphere;
Stage #2: trimethylsilyl trifluoromethanesulfonate; 1,2-anhydro-3,4,6-tri-O-benzyl-β-D-mannopyranose at 60℃; for 3h; Inert atmosphere;
79%
1,2,3,5-tetra-O-acetyl-3-C-ethynyl-D-ribo-pentofuranose
848644-37-1

1,2,3,5-tetra-O-acetyl-3-C-ethynyl-D-ribo-pentofuranose

5-chlorouracil
1820-81-1

5-chlorouracil

1-[2,3,5-tri-O-acetyl-3-C-ethynyl-β-D-ribo-pentofuranosyl]-5-chlorouracil
848644-41-7

1-[2,3,5-tri-O-acetyl-3-C-ethynyl-β-D-ribo-pentofuranosyl]-5-chlorouracil

Conditions
ConditionsYield
With N,O-bis-(trimethylsilyl)-acetamide; trimethylsilyl trifluoromethanesulfonate In acetonitrile at 50℃; for 29h;78%
5-chlorouracil
1820-81-1

5-chlorouracil

acrylonitrile
107-13-1

acrylonitrile

C7H6ClN3O2

C7H6ClN3O2

Conditions
ConditionsYield
With triethylamine In water at 100℃; for 0.0833333h; Michael addition; microwave irradiation;78%
5-chlorouracil
1820-81-1

5-chlorouracil

(bromomethyl)pentafluorobenzene
1765-40-8

(bromomethyl)pentafluorobenzene

N1,N3-bis(pentafluorobenzyl)-5-chlorouracil

N1,N3-bis(pentafluorobenzyl)-5-chlorouracil

Conditions
ConditionsYield
With N-ethyl-N,N-diisopropylamine In methanol at 42℃; for 2h;77%
5-chlorouracil
1820-81-1

5-chlorouracil

chromium chloride hexahydrate

chromium chloride hexahydrate

Cr(3+)*C4H2N2O2Cl(1-)*C6H8N3O2(1-)*H2O*Cl(1-) = Cr(C4H2N2O2Cl)(C6H8N3O2)(H2O)Cl
203308-39-8

Cr(3+)*C4H2N2O2Cl(1-)*C6H8N3O2(1-)*H2O*Cl(1-) = Cr(C4H2N2O2Cl)(C6H8N3O2)(H2O)Cl

Conditions
ConditionsYield
With triethyl formate; aq. NaOH In ethanol; water addn. aq. histidine to pptd. (pH 5-6, aq. NaOH) suspn. of metal/5-chlorouracil complex in ethanol; pptn. on concn. and ether addn., drying (vac., 50°C); elem. anal.;75%
5-chlorouracil
1820-81-1

5-chlorouracil

allyl bromide
106-95-6

allyl bromide

N-allyl 5-chlorouracil

N-allyl 5-chlorouracil

Conditions
ConditionsYield
With sodium hydroxide In water at 100℃; for 0.166667h; Microwave irradiation; regioselective reaction;75%
5-chlorouracil
1820-81-1

5-chlorouracil

5-chloro-6-deuteropyrimidine-2,4(1H,3H)-dione

5-chloro-6-deuteropyrimidine-2,4(1H,3H)-dione

Conditions
ConditionsYield
With [D]-sodium hydroxide; sodium In water-d2 at 0 - 120℃; Inert atmosphere;75%
5-chlorouracil
1820-81-1

5-chlorouracil

4-Fluoronitrobenzene
350-46-9

4-Fluoronitrobenzene

5-chloro-1-(4-nitro-phenyl)-1H-pyrimidine-2,4-dione

5-chloro-1-(4-nitro-phenyl)-1H-pyrimidine-2,4-dione

Conditions
ConditionsYield
Stage #1: 5-chlorouracil With potassium carbonate In dimethyl sulfoxide at 80℃; for 0.5h;
Stage #2: 4-Fluoronitrobenzene In dimethyl sulfoxide at 70 - 80℃;
74%
5-chlorouracil
1820-81-1

5-chlorouracil

thiophenol
108-98-5

thiophenol

5-(phenylsulfanyl)-2,4(1H,3H)-pyrimidinedione
1137-90-2

5-(phenylsulfanyl)-2,4(1H,3H)-pyrimidinedione

Conditions
ConditionsYield
With potassium carbonate In ethylene glycol at 130 - 140℃; for 2h;71%
iron(III) chloride hexahydrate

iron(III) chloride hexahydrate

5-chlorouracil
1820-81-1

5-chlorouracil

Fe(3+)*C4H2N2O2Cl(1-)*C6H8N3O2(1-)*H2O*Cl(1-) = Fe(C4H2N2O2Cl)(C6H8N3O2)(H2O)Cl
203308-40-1

Fe(3+)*C4H2N2O2Cl(1-)*C6H8N3O2(1-)*H2O*Cl(1-) = Fe(C4H2N2O2Cl)(C6H8N3O2)(H2O)Cl

Conditions
ConditionsYield
With triethyl formate; aq. NaOH In ethanol; water addn. aq. histidine to pptd. (pH 5-6, aq. NaOH) suspn. of metal/5-chlorouracil complex in ethanol; pptn. on concn. and ether addn., drying (vac., 50°C); elem. anal.;70%
5-chlorouracil
1820-81-1

5-chlorouracil

chromium chloride hexahydrate

chromium chloride hexahydrate

Cr(3+)*C4H2N2O2Cl(1-)*OH(1-)*Cl(1-) = Cr(C4H2N2O2Cl)(OH)Cl

Cr(3+)*C4H2N2O2Cl(1-)*OH(1-)*Cl(1-) = Cr(C4H2N2O2Cl)(OH)Cl

Conditions
ConditionsYield
With triethyl orthoformate In ethanol refluxing (2-3 h); pptn. (pH 5-6, aq. NaOH), washing (ethanol), drying (vac., 50°C);elem. anal.;70%

5-Chlorouracil Specification

The 5-Chlorouracil, with the CAS registry number 1820-81-1 and EINECS registry number 217-339-7, has the IUPAC name of 5-chloro-1H-pyrimidine-2,4-dione. It is a kind of white to light beige crystalline powder, and belongs to the following product categories: Pyridines, Pyrimidines, Purines and Pteredines; Pyrimidine series; Heterocyclic Compounds; Biochemistry; Nucleobases and their analogs; Nucleosides, Nucleotides & Related Reagents; Nucleic acids; Bases & Related Reagents; Heterocycles; Nucleotides. The molecular formula of the chemical is C4H3ClN2O2. What's more, it is always used for the experimental and clinical treatment of neoplastic and viral diseases.

The physical properties of 5-Chlorouracil are as followings: (1)ACD/LogP: -0.52; (2)# of Rule of 5 Violations: 0; (3)ACD/LogD (pH 5.5): -0.52; (4)ACD/LogD (pH 7.4): -0.78; (5)ACD/BCF (pH 5.5): 1; (6)ACD/BCF (pH 7.4): 1; (7)ACD/KOC (pH 5.5): 12.35; (8)ACD/KOC (pH 7.4): 6.76; (9)#H bond acceptors: 4; (10)#H bond donors: 2; (11)#Freely Rotating Bonds: 0; (12)Polar Surface Area: 40.62 Å2; (13)Index of Refraction: 1.587; (14)Molar Refractivity: 30.56 cm3; (15)Molar Volume: 90.9 cm3; (16)Polarizability: 12.11×10-24cm3; (17)Surface Tension: 57.3 dyne/cm; (18)Density: 1.61 g/cm3; (19)Flash Point: 203.9 °C; (20)Enthalpy of Vaporization: 69.22 kJ/mol; (21)Boiling Point: 413.6 °C at 760 mmHg; (22)Vapour Pressure: 1.98E-07 mmHg at 25°C. 

Uses of 5-Chlorouracil: It can react with chloro-trimethyl-silane to produce 5-Chloro-2,4-bis(trimethylsiloxy)pyrimidine. This reaction will need reagent hexamethylsilazane, and the yield is about 99%.   

You should be cautious while dealing with this chemical. It irritates to eyes, respiratory system and skin. Therefore, you had better take the following instructions: Do not breathe dust and avoid contacting with skin and eyes; Wear suitable protective clothing, and in case of contacting with eyes, rinse immediately with plenty of water and seek medical advice.

You can still convert the following datas into molecular structure:
(1)SMILES: Cl/C1=C/NC(=O)NC1=O
(2)InChI: InChI=1/C4H3ClN2O2/c5-2-1-6-4(9)7-3(2)8/h1H,(H2,6,7,8,9)
(3)InChIKey: ZFTBZKVVGZNMJR-UHFFFAOYAS